Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
REVIUM Rx
reviumrx.comAI Executive Summary
AI-powered analysis of 8-K filing content
REVIUM Rx announced the appointment of Igor Bluvstein as Chief Financial Officer effective May 27, 2026, following the resignation of Arie Gordashnikov. This leadership transition may signal a shift in financial strategy as the company continues operations.
Key Takeaways
Arie Gordashnikov resigned as CFO effective immediately with no disagreements cited regarding company operations or policies
Igor Bluvstein appointed as new CFO, bringing prior CFO experience from Argent BioPha (2024-2025)
2 more takeaways